Production (Stage)
Vigil Neuroscience, Inc.
VIGL
$7.89
$0.010.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -86.73M | -84.26M | -82.60M | -83.84M | -82.78M |
| Total Depreciation and Amortization | 464.00K | 453.00K | 453.00K | 449.00K | 447.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.51M | 9.96M | 10.47M | 9.87M | 9.20M |
| Change in Net Operating Assets | 22.52M | 22.62M | 23.09M | 3.31M | 3.08M |
| Cash from Operations | -53.24M | -51.22M | -48.59M | -70.21M | -70.06M |
| Capital Expenditure | -290.00K | -5.00K | -18.00K | -65.00K | -182.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.81M | 8.77M | 11.61M | 43.54M | 20.51M |
| Cash from Investing | 15.52M | 8.76M | 11.59M | 43.48M | 20.33M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -2.00K | -12.00K |
| Issuance of Common Stock | 17.76M | 9.68M | 5.30M | 5.30M | 5.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 19.81M | 19.81M | 19.81M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 37.57M | 29.49M | 25.11M | 5.30M | 5.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.00K | -12.97M | -11.90M | -21.43M | -43.86M |